For the millions of Australians living with asthma or seasonal allergies, summer isn't just about making the most of long, ...

The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. | Tuesday ...

Depemokimab-ulaa (Exdensur) has been approved by the US FDA as add-on maintenance therapy for severe asthma with an ...

Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two ...

The MarketWatch News Department was not involved in the creation of this content.-- Windward Bio and Qyuns Therapeutics announce licensing agreement for WIN027, a highly potent, l ...

The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...

GSK has struck a voluntary agreement with the US government to lower the cost of prescription medicines, and expand access to ...

Asthma affects over 400 million people worldwide, requiring careful management to control symptoms and reduce the risk of attacks. While there is no cure, identifying key triggers and adopting proper ...

Learn how to improve indoor air quality with effective air purification tips. Reduce allergens, ease asthma symptoms, and create a cleaner home environment.

Having a severe allergy doesn’t just affect physical health - it’s often the social isolation and mental toll of dealing with a somewhat ‘invisible condition’ that people with allergies also have to ...